Skip to main content
. 2019 May 18;68(7):1095–1106. doi: 10.1007/s00262-019-02346-4

Fig. 4.

Fig. 4

Immunotherapy induces CD8+ TIL reinvigoration. Mice with established B16 tumors were treated with ICB or PBS control on days 8, 11, and 14 post-tumor injection. Tumors were harvest on day 16 and analyzed by flow cytometry. a Representative flow plots of CD8+ TIL from mice treated with PBS control or ICB. Red quadrant and inset numbers in the top panels are the percentage of Eomes+ PD1+ CD8+ TIL. Red contour in the bottom panels are reinvigorated (Eomes+ PD-1+ T-bet+ Ki67+) CD8+ TIL taken from the red quadrant above. Inset numbers are the percentage of reinvigorated CD8+ TIL. Pooled data for exhausted (b) and reinvigorated (c) CD8+ TIL (n = 17) are displayed from five independent experiments. P values are indicated above each treatment group